RecruitingNot ApplicableNCT06335992

Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.

Activation of Regenerative Pathways by Exercise Training in Patients With Chronic Obstructive Pulmonary Disease


Sponsor

Uppsala University

Enrollment

80 participants

Start Date

Sep 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identify (or validate) biomarkers mirroring systemic processes such as reduced inflammation and ameliorating the epithelial barrier in these patients. These events may additionally act as potential targets for interventions. Objectives (i) Evaluate biomarkers for regenerative processes, matrix turnover, stem cell activity and inflammatory patterns in lung tissue biopsies, blood- and urine samples correlated to vital lung parameters and physical capacity, before and after attending an exercise-training program. (ii) Study the effects of exercise training on the pulmonary ventilation/perfusion ratio and quality of life. (iii) Evaluate the relation between pathophysiology in the lung evaluated by CT scan, and systemic response measured by muscle biopsies and biomarkers in blood/urine. (iv) Investigate in vitro cell behaviour and remodelling/regenerative processes altered in COPD patients upon exercise training (aim 1).


Eligibility

Min Age: 50 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a structured exercise training program can promote tissue repair and regeneration in people with COPD (chronic obstructive pulmonary disease), a progressive lung condition that causes difficulty breathing. **You may be eligible if...** - You have COPD with moderate-to-severe airflow limitation (FEV1 between 30–85% of predicted after bronchodilator) - You are on optimal medical treatment according to established COPD guidelines - You have not smoked for at least one year - You have not had a COPD flare-up in the last 4 weeks - Your BMI is between 18 and 35 **You may NOT be eligible if...** - You are currently smoking - You have unstable heart or lung disease - You already regularly attend specially designed exercise rehabilitation sessions - You have other serious conditions that limit your ability to exercise safely Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise regime

Exercise


Locations(2)

Lund University

Lund, Sweden

Uppsala University

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06335992


Related Trials